GO:0072711 cellular response to hydroxyurea: DNA Replication Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072711 (cellular response to hydroxyurea) describes how a cell changes its state or activity after exposure to hydroxyurea, a ribonucleotide reductase inhibitor that stalls DNA replication.
• Hydroxyurea induces replication stress and DNA damage responses, recruiting proteins such as BLM and FANCD2 to stalled forks and damage sites.
• The APC protein regulates the cellular response to replication stress, linking hydroxyurea signaling to cell cycle and cytoskeletal control.
• Hydroxyurea is a standard therapy for sickle cell anemia and beta-thalassemia, where cellular responses correlate with fetal hemoglobin induction and clinical response.
• Micronuclei induced by hydroxyurea-driven replication stress do not activate cGAS-STING, distinguishing this response from other DNA damage pathways.
• Studying GO:0072711 requires integrated approaches including CRISPR knockout, point mutation, knock-in, overexpression, and CRISPR library screening to dissect causal genes.
Description
Hydroxyurea (HU) is a well-established inhibitor of ribonucleotide reductase that depletes deoxynucleotide pools and stalls DNA replication forks, thereby triggering a complex cellular response known as the cellular response to hydroxyurea (GO:0072711). This biological process encompasses changes in gene expression, cell cycle progression, DNA repair, and survival signaling that occur when a cell senses hydroxyurea-induced replication stress. Understanding this response is critical because hydroxyurea is not only a widely used chemotherapeutic and sickle cell therapeutic agent but also a powerful experimental tool to study replication stress and genome stability. The QuickGO definition states that GO:0072711 is any process that results in a change in state or activity of a cell as a result of a hydroxyurea stimulus, including movement, secretion, enzyme production, and gene expression. Research into this term has revealed key roles for proteins such as Bloom syndrome protein (BLM) and FANCD2 in responding to hydroxyurea-mediated DNA synthesis inhibition. Additionally, the adenomatous polyposis coli (APC) protein has been shown to regulate the cellular response to DNA replication stress, further linking hydroxyurea signaling to cell cycle and cytoskeletal dynamics. In clinical contexts, the cellular response to hydroxyurea underlies fetal hemoglobin induction in sickle cell anemia and beta-thalassemia, where in vitro erythroid cultures can predict patient response. Recent work also indicates that micronuclei induced by hydroxyurea do not activate cGAS-STING, highlighting specificity in the DNA damage response. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0072711, its mechanisms, key genes, disease relevance, and experimental models.
cellular response to hydroxyurea At A Glance
| GO ID | GO:0072711 |
|---|---|
| GO term | cellular response to hydroxyurea |
| Ontology | biological_process |
| Synonym | cellular response to HU |
| Definition | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyurea stimulus. |
| Major function | Mediates cellular adaptation to hydroxyurea-induced replication stress and DNA damage. |
| Key proteins | BLM, FANCD2, APC, and other replication stress response factors. |
| Clinical relevance | Predicts response to hydroxyurea therapy in sickle cell anemia and beta-thalassemia. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, CRISPR library screening, and bioinformatics. |
What Is GO:0072711?
GO:0072711, cellular response to hydroxyurea, is defined by QuickGO as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyurea stimulus. In other words, it captures the entire set of cellular reactions triggered when a cell encounters hydroxyurea, a drug that inhibits ribonucleotide reductase and causes replication fork stalling. This response includes activation of DNA damage checkpoints, recruitment of repair proteins, modulation of cell cycle progression, and changes in gene expression programs that help the cell cope with replication stress.
Why Is cellular response to hydroxyurea Important in Cell Biology?
The cellular response to hydroxyurea (GO:0072711) is critically important because hydroxyurea is a mainstay therapy for sickle cell anemia and beta-thalassemia, and the cellular pathways it activates determine both therapeutic efficacy and potential resistance. Moreover, hydroxyurea is a widely used experimental tool to induce replication stress, making GO:0072711 a central node for understanding how cells maintain genome stability, activate DNA repair, and coordinate cell cycle checkpoints. Dysregulation of this response contributes to cancer progression, chemoresistance, and bone marrow failure syndromes, underscoring its broad biomedical significance.
• Hydroxyurea is a first-line therapy for sickle cell anemia, and cellular responses correlate with fetal hemoglobin induction and clinical improvement.
• In beta-thalassemia, quantification of HBG mRNA in primary erythroid cultures can predict response to hydroxyurea.
• The response to hydroxyurea involves DNA replication stress signaling, with BLM and FANCD2 playing key roles in fork protection and repair.
• APC protein regulates the cellular response to replication stress, linking hydroxyurea signaling to cell cycle and cytoskeletal control.
• Micronuclei induced by hydroxyurea do not activate cGAS-STING, revealing pathway specificity in DNA damage responses.
• Understanding GO:0072711 aids in identifying biomarkers for hydroxyurea resistance in cancer and hemoglobinopathies.
• CRISPR-based models enable causal dissection of genes involved in the hydroxyurea response, accelerating therapeutic target discovery.
• The term is essential for interpreting genome-wide screens that use hydroxyurea as a replication stress inducer.
What Happens During cellular response to hydroxyurea?
Hydroxyurea sensing and replication fork stalling
In simple terms: Hydroxyurea blocks the production of DNA building blocks, causing the DNA copying machinery to stall.
Hydroxyurea inhibits ribonucleotide reductase, depleting deoxynucleotide pools and causing DNA replication forks to stall. This stalling is sensed by cellular surveillance mechanisms that initiate the cellular response to hydroxyurea, including activation of checkpoint kinases and recruitment of replication stress response proteins.
Recruitment of DNA repair and replication stress proteins
In simple terms: Specialized proteins rush to the stalled DNA forks to protect and repair them.
In response to hydroxyurea, proteins such as Bloom syndrome protein (BLM) and FANCD2 are recruited to sites of stalled replication and DNA damage. BLM responds to hydroxyurea-mediated DNA synthesis inhibition, while non-ubiquitinated FANCD2 plays a novel role in the response to hydroxyurea-induced DNA damage. The APC protein also regulates the cellular response to DNA replication stress, influencing cell cycle progression.
Cell cycle checkpoint activation and gene expression changes
In simple terms: The cell pauses its cycle and changes which genes are turned on or off to survive the stress.
Hydroxyurea exposure leads to changes in gene expression and cell cycle arrest, allowing time for repair. The cellular response includes modulation of enzyme production and secretion as defined by GO:0072711, with APC playing a role in regulating this response. These transcriptional and post-translational changes help the cell cope with replication stress.
Micronuclei formation and cGAS-STING non-activation
In simple terms: DNA fragments may form small structures outside the nucleus, but they do not trigger a specific immune alarm.
Hydroxyurea-induced replication stress can lead to micronuclei formation, but these micronuclei do not activate the cGAS-STING pathway, distinguishing this response from other DNA damage contexts. This specificity highlights that the cellular response to hydroxyurea is tailored and does not universally engage innate immune signaling.
Clinical response in erythroid cells
In simple terms: In blood cells, hydroxyurea triggers production of fetal hemoglobin, which helps patients with sickle cell disease.
In erythroid cells, the cellular response to hydroxyurea includes induction of fetal hemoglobin (HbF), which is beneficial in sickle cell anemia and beta-thalassemia. BFU-E colony growth in response to hydroxyurea correlates with in vivo fetal hemoglobin induction, and early detection of response can be monitored in patients. Quantification of HBG mRNA in primary erythroid cultures predicts response to hydroxyurea.
Key Genes Involved in GO:0072711 cellular response to hydroxyurea
The following genes and proteins are central to the cellular response to hydroxyurea (GO:0072711), based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BLM | Bloom syndrome protein; responds to hydroxyurea-mediated DNA synthesis inhibition | Studied for replication fork protection and genome stability |
| FANCD2 | Non-ubiquitinated form plays a role in response to hydroxyurea-induced DNA damage | Fanconi anemia pathway and DNA crosslink repair |
| APC | Regulates cellular response to DNA replication stress | Links replication stress to cell cycle and cytoskeleton |
| HBG1 | Fetal hemoglobin gamma globin; induced in erythroid cells by hydroxyurea | Predicts hydroxyurea response in hemoglobinopathies |
| HBG2 | Fetal hemoglobin gamma globin; induced by hydroxyurea | Biomarker for hydroxyurea therapy |
| HBB | Beta globin; mutated in sickle cell anemia; hydroxyurea increases HbF | Therapeutic target in sickle cell disease |
| cGAS | Cyclic GMP-AMP synthase; not activated by hydroxyurea-induced micronuclei | Innate immune sensing of DNA damage |
| STING | Stimulator of interferon genes; not activated by hydroxyurea-induced micronuclei | DNA damage and immune signaling |
| RPA | Replication protein A; binds single-stranded DNA at stalled forks | Replication stress marker |
| ATR | Ataxia telangiectasia and Rad3-related kinase; master regulator of replication stress | Checkpoint activation |
| CHEK1 | Checkpoint kinase 1; downstream of ATR in replication stress | Cell cycle arrest and repair |
| BRCA1 | Breast cancer 1; involved in homologous recombination repair | DNA repair and chemoresistance |
| BRCA2 | Breast cancer 2; homologous recombination | Fanconi anemia and cancer |
| FANCA | Fanconi anemia complementation group A | Crosslink repair and hydroxyurea sensitivity |
| FANCC | Fanconi anemia complementation group C | Replication stress response |
| PCNA | Proliferating cell nuclear antigen; sliding clamp at replication forks | Replication and repair |
| CDK1 | Cyclin-dependent kinase 1; cell cycle regulation | Checkpoint control |
How Is cellular response to hydroxyurea Regulated?
The cellular response to hydroxyurea is regulated by the ATR-CHK1 checkpoint pathway, which senses stalled replication forks and coordinates cell cycle arrest and repair. BLM and FANCD2 are recruited to stalled forks in a regulated manner, and their functions are modulated by ubiquitination and phosphorylation. APC regulates this response, linking it to cell cycle progression and cytoskeletal dynamics. Additionally, the response is influenced by deoxynucleotide pool levels and ribonucleotide reductase activity, which are the direct targets of hydroxyurea.
cellular response to hydroxyurea and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HBB | Sickle cell anemia; hydroxyurea induces HbF | Knock-in of sickle mutation in HBB; erythroid differentiation |
| HBG1/HBG2 | Beta-thalassemia; HBG mRNA predicts hydroxyurea response | Overexpression or reporter knock-in in erythroid cells |
| FANCD2 | Fanconi anemia; role in hydroxyurea-induced DNA damage | Knockout and point mutation in cell lines |
| BLM | Bloom syndrome; responds to hydroxyurea | Knockout and tagged knock-in for imaging |
| APC | Colorectal cancer; regulates replication stress response | Knockout and point mutation in colorectal cell lines |
Sickle cell anemia and beta-thalassemia
Hydroxyurea is a standard therapy for sickle cell anemia and beta-thalassemia, where the cellular response to hydroxyurea induces fetal hemoglobin (HbF) and reduces disease severity. BFU-E colony growth in response to hydroxyurea correlates with in vivo fetal hemoglobin induction, and early detection of response can guide therapy. Quantification of HBG mRNA in primary erythroid cultures predicts response to hydroxyurea in both sickle cell disease and beta-thalassemia.
Cancer and chemoresistance
The cellular response to hydroxyurea is relevant to cancer because hydroxyurea is used as a chemotherapeutic agent, and alterations in replication stress response genes such as BLM, FANCD2, and APC can affect sensitivity or resistance. Understanding these pathways may inform combination therapies and biomarkers for hydroxyurea-based treatments.
Fanconi anemia and genome instability
FANCD2, a key player in the cellular response to hydroxyurea, is mutated in Fanconi anemia, a disorder characterized by bone marrow failure and cancer predisposition. The non-ubiquitinated form of FANCD2 has a specific role in responding to hydroxyurea-induced DNA damage, linking this GO term to genome instability syndromes.
Innate immune signaling and micronuclei
Although hydroxyurea induces micronuclei, these do not activate cGAS-STING, suggesting that the cellular response to hydroxyurea avoids triggering innate immune responses under certain conditions. This has implications for understanding how replication stress intersects with inflammation in diseases such as cancer and autoimmunity.
From cellular response to hydroxyurea-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate hydroxyurea-induced replication stress response? | CRISPR knockout in HeLa or U2OS cells followed by hydroxyurea treatment |
| Does a specific point mutation in FANCD2 affect hydroxyurea sensitivity? | Point mutation knock-in using CRISPR in patient-derived fibroblasts |
| How does BLM localization change upon hydroxyurea? | Tagged knock-in of BLM with fluorescent protein |
| Does overexpression of HBG1 increase HbF induction by hydroxyurea? | Overexpression in erythroid progenitor cells |
| Which genes are essential for survival under hydroxyurea? | Genome-wide CRISPR library screening |
| Does APC regulate cell cycle after hydroxyurea? | APC knockout and rescue with wild-type or mutant |
How to Study the cellular response to hydroxyurea Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on hydroxyurea sensitivity | Identify essential genes in replication stress response |
| Point mutation knock-in | Specific amino acid function in hydroxyurea response | Study FANCD2 non-ubiquitinated form |
| Tagged knock-in | Protein localization and dynamics | Image BLM at stalled forks |
| Overexpression | Gain-of-function and rescue | Test HBG1 induction in erythroid cells |
| CRISPR library screening | Genome-wide fitness under hydroxyurea | Discover novel response genes |
| RNA-seq | Transcriptional changes after hydroxyurea | Measure HBG mRNA for response prediction |
| Immunofluorescence | Protein recruitment to damage sites | Visualize FANCD2 foci after hydroxyurea |
| Bioinformatics pathway analysis | Enrichment of GO terms and networks | Interpret screen hits in GO:0072711 context |
CRISPR knockout and point mutation
CRISPR knockout of candidate genes such as BLM, FANCD2, and APC followed by hydroxyurea treatment can reveal their causal roles in the cellular response to hydroxyurea. Point mutations can be introduced to study specific functional domains, such as the non-ubiquitinated form of FANCD2.
Knock-in and tagged knock-in
Knock-in of fluorescent tags or epitope tags allows real-time imaging and biochemical analysis of proteins like BLM at stalled replication forks after hydroxyurea exposure. Tagged knock-in of HBG1 can monitor fetal hemoglobin induction in erythroid cells.
Overexpression and rescue experiments
Overexpression of wild-type or mutant genes can test sufficiency and rescue phenotypes in knockout backgrounds, particularly for APC and FANCD2 in hydroxyurea response. Overexpression of HBG1 in erythroid progenitors can enhance HbF production.
CRISPR library screening and bioinformatics
Genome-wide CRISPR knockout or activation screens under hydroxyurea selection can identify novel genes required for survival or sensitivity. Bioinformatics analysis of screen data, combined with pathway enrichment, can pinpoint GO:0072711-related networks.
How CRISPR Can Be Used to Study GO:0072711 cellular response to hydroxyurea
Knockout
CRISPR knockout of genes such as BLM, FANCD2, and APC in cell lines followed by hydroxyurea treatment can determine whether they are required for the cellular response to hydroxyurea. For example, FANCD2 knockout increases sensitivity to hydroxyurea-induced DNA damage.
Point Mutation
Point mutation knock-in can dissect specific residues or domains, such as the non-ubiquitinated form of FANCD2, to test their role in hydroxyurea response. This approach avoids confounding effects of complete protein loss.
Knock-in
Knock-in of reporter genes or tags, such as fluorescently tagged BLM, enables live-cell imaging of protein recruitment to stalled replication forks after hydroxyurea. Knock-in of HBG1 reporters can monitor fetal hemoglobin induction.
Overexpression
Overexpression of wild-type or mutant cDNAs in knockout backgrounds can test sufficiency and rescue of hydroxyurea phenotypes, particularly for APC and FANCD2. Overexpression of HBG1 in erythroid progenitors can enhance HbF production.
How EDITGENE Supports cellular response to hydroxyurea Research
Researchers studying cellular response to hydroxyurea-related genes often need to determine whether a candidate gene is causally involved in replication stress signaling, DNA repair, or clinical response to hydroxyurea. EDITGENE provides comprehensive CRISPR-based services to enable such causal studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for cellular response to hydroxyurea research.
Frequently Asked Questions About cellular response to hydroxyurea
What is GO:0072711 cellular response to hydroxyurea?
GO:0072711 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell as a result of a hydroxyurea stimulus, including changes in gene expression, movement, and secretion.
What genes are involved in the cellular response to hydroxyurea?
Key genes include BLM, FANCD2, APC, HBG1, HBG2, and HBB, which mediate replication stress response, DNA repair, and fetal hemoglobin induction.
How does hydroxyurea affect DNA replication?
Hydroxyurea inhibits ribonucleotide reductase, depleting deoxynucleotides and stalling DNA replication forks, which triggers the cellular response to hydroxyurea.
What is the role of BLM in hydroxyurea response?
Bloom syndrome protein (BLM) responds to hydroxyurea-mediated DNA synthesis inhibition and is recruited to stalled replication forks.
How does FANCD2 respond to hydroxyurea?
Non-ubiquitinated FANCD2 plays a novel role in response to hydroxyurea-induced DNA damage, independent of its ubiquitination.
Does hydroxyurea activate cGAS-STING?
No, micronuclei induced by hydroxyurea do not activate cGAS-STING, unlike micronuclei from other sources.
How is hydroxyurea used in sickle cell anemia?
Hydroxyurea induces fetal hemoglobin (HbF) through the cellular response to hydroxyurea, reducing disease severity, and response can be predicted by BFU-E colony growth and HBG mRNA levels.
What experimental models are used to study GO:0072711?
CRISPR knockout, point mutation, knock-in, overexpression, and CRISPR library screening in cell lines and primary erythroid cultures are commonly used.
What is the role of APC in replication stress?
APC regulates the cellular response to DNA replication stress, linking hydroxyurea signaling to cell cycle and cytoskeletal control.
How can I study the cellular response to hydroxyurea with CRISPR?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to dissect genes involved in GO:0072711.
Conclusion
GO:0072711, cellular response to hydroxyurea, is a critical biological process that coordinates DNA replication stress signaling, DNA repair, cell cycle checkpoints, and gene expression changes. Key proteins such as BLM, FANCD2, and APC, along with fetal hemoglobin genes, play central roles in this response, with direct clinical relevance to sickle cell anemia, beta-thalassemia, and cancer. Understanding this process requires integrated experimental approaches, and CRISPR-based models offer powerful tools to dissect causal mechanisms. EDITGENE provides comprehensive services to accelerate research into GO:0072711 and its associated genes.
References
- 2. Takaki T et al.. 2024. Micronuclei induced by radiation, replication stress, or chromosome segregation errors do not activate cGAS-STING.. Mol Cell 84(11):2203-2213.e5 PMID: 38749421
- 3. Ababou M et al.. 2002. Bloom's syndrome protein response to ultraviolet-C radiation and hydroxyurea-mediated DNA synthesis inhibition.. Oncogene 21(13):2079-88 PMID: 11960380
- 4. Chen X et al.. 2016. A novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.. Oncogene 35(1):22-34 PMID: 25893307
- 5. Yang YM et al.. 1997. BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction.. Am J Hematol 56(4):252-8 PMID: 9395188
- 6. Ballas SK et al.. 2010. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.. Hemoglobin 34(5):424-9 PMID: 20854115
- 7. Brocardo MG et al.. 2011. Adenomatous polyposis coli protein regulates the cellular response to DNA replication stress.. Int J Biochem Cell Biol 43(9):1354-64 PMID: 21664290
- 8. Pecoraro A et al.. 2014. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.. Eur J Haematol 92(1):66-72 PMID: 24112139
